Johnson & Johnson Wins FDA Approval for Ottava Robotic Surgery System, Challenging Intuitive Surgical's Market Dominance
Johnson & Johnson has secured FDA approval for its Ottava robotic surgical system for multiple upper abdominal procedures, marking the company's entry into the competitive robotic surgery market currently dominated by Intuitive Surgical's da Vinci system.